Discovery
Medicinal Chemistry Services
Discovery ADME
- Metabolic Stability
- CYP Interaction
- Permeability & Transporters
- Physicochemical Properties
- Protein Binding
We are a full spectrum CDMO with Formulation, Analytical, and Novel Drug Delivery platforms supporting NCE, 505b(2), and ANDA products from pre-clinical through Phase III Clinical Trial Material (CTM) manufacturing.
Our facilities house the latest analytical instrumentation for a full range of testing, including API/Product release, stability, and dissolution.
Our broad portfolio of Product Development and CMC services spans drug product development, analysis, and clinical trial materials’ delivery and supply, from preclinical stages through Phase III Clinical Trial Material (CTM) Manufacturing.
We have proven expertise and a successful track record in the following areas:
Our Formulation development staff have the experience to develop a variety of finished products. These include:
Our scientists have hands-on experience and have published in scientific journals on the following novel drug delivery technologies.
With an outstanding compliance history, the CMC team at Frontage operates under strict adherence to ICH and US FDA GMP guidelines. Our CMC facilities and processes undergo routine audits and inspections from sponsors and regulatory authorities.